Studies immune cells called monocytes in people with myeloproliferative blood disorders
Examines monocyte cells at diagnosis in adults with myeloproliferative neoplasms.
Plain-language title generated from the registry record
Registry title: Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes
Key facts
- Where
- Angers, Cholet, and Saumur, FranceSee the 3 sites
Where in France
- GOUBAND AgatheAngers, FranceTaking people
- BESCOND CharlesCholet, FranceNot yet recruiting
- TRUCHAN-GRACZYK MalgorzataSaumur, FranceNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Angers
- Trial code
- NCT06361641
- Record updated
- 29 October 2026
- Original description
Prospective study for functional and phenotypic characterization of monocytes in philadelphia-negative myeloproliferative neoplasmsRead full original descriptionShow less
Functional and Phenotypic Characterization of Monocytes in Myeloproliferative Syndromes-PHEMOP
Prospective study for functional and phenotypic characterization of monocytes in philadelphia-negative myeloproliferative neoplasms
Inclusion: Diagnosis of PV, ET, pre-myelofibrosis or primary myelofibrosis according to WHO 2022 criteria (including BOM for ET, premyelofibrosis and primary myelofibrosis); Patient who has not received treatment specific to hemopathy at the time of sampling; Obtaining the signature of consent to participate in the study; Patient having consented to be included in the "Malignant Hemopathy" collection of Angers University Hospital and in FIMBANK database.
Exclusion: Patient with another hemopathy or another active cancer at the time of diagnosis; Minor patient at diagnosis (< 18 years old); Person not affiliated to a social security scheme or beneficiary of such a scheme; Patient not capable or without agreement from the guardian or legal representative.